Detalles de la búsqueda
1.
Patient preferences in the treatment of stage III/IV classic Hodgkin lymphoma: Results from the CONNECT cross-sectional survey.
Br J Haematol;
204(4): 1262-1270, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38323849
2.
Physician frontline treatment preferences for stage III/IV classic Hodgkin lymphoma: the real-world US CONNECT study.
Future Oncol;
20(12): 749-760, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37665273
3.
The impact of classic Hodgkin lymphoma on informal caregivers: results from the CONNECT cross-sectional survey.
Support Care Cancer;
31(12): 664, 2023 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37914825
4.
Observations of Oncologists on Treatment Selection With Interim Positron Emission Tomography-Adapted Approaches in Classic Hodgkin Lymphoma: The Real-World CONNECT Study.
JCO Oncol Pract;
19(6): e867-e876, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36947720
5.
Retrospective Analysis With Propensity Score Matching of Peripheral T-Cell Lymphoma Treated Frontline With Brentuximab Vedotin and Chemotherapy.
Oncologist;
28(6): 520-530, 2023 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36971492
6.
Safety and Efficacy of Vorinostat Plus Sirolimus or Everolimus in Patients with Relapsed Refractory Hodgkin Lymphoma.
Clin Cancer Res;
26(21): 5579-5587, 2020 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33055173
7.
Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma.
J Clin Oncol;
38(22): 2519-2529, 2020 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32453640
8.
A phase 1 trial of alisertib and romidepsin for relapsed/refractory aggressive B-cell and T-cell lymphomas.
Haematologica;
105(1): e26-e28, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31073068
9.
Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.
Head Neck;
41(5): 1546, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30990235
10.
Lenalidomide plus rituximab (R2 ) in previously untreated marginal zone lymphoma: subgroup analysis and long-term follow-up of an open-label phase 2 trial.
Br J Haematol;
185(5): 874-882, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30919940
11.
Long-term overall- and progression-free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non-Hodgkin lymphoma.
Br J Haematol;
185(4): 670-678, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30820940
12.
Stage I non-Hodgkin lymphoma: no plateau in disease-specific survival ?
Ann Hematol;
98(5): 1169-1176, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30617643
13.
Outcome of patients with relapsed or refractory anaplastic large cell lymphoma who have failed brentuximab vedotin.
Hematol Oncol;
37(1): 35-38, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30209819
14.
Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation Burden.
Oncologist;
24(2): 219-228, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30108156
15.
Prevalence of a Histologic Change of Ocular Adnexal Lymphoma in Patients With a History of Lymphoma.
Ophthalmic Plast Reconstr Surg;
35(3): 243-246, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30124609
16.
ABVD plus rituximab versus ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: a randomized phase 2 study.
Haematologica;
104(2): e65-e67, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30190343
17.
Stage I Non-Hodgkin Lymphoma: difference in survival outcome by primary extranodal site of involvement.
Br J Haematol;
185(2): 334-338, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29978452
18.
Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study.
Lancet Haematol;
5(12): e609-e617, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30501868
19.
Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapy.
Adv Radiat Oncol;
3(4): 639-646, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30370365
20.
Beyond Chemotherapy: Checkpoint Inhibition and Cell-Based Therapy in Non-Hodgkin Lymphoma.
Am Soc Clin Oncol Educ Book;
38: 592-603, 2018 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-30231316